JP2017516510A - 薬物の効果及び相互作用を非侵襲的にモニタ及び識別するための方法並びに装置 - Google Patents

薬物の効果及び相互作用を非侵襲的にモニタ及び識別するための方法並びに装置 Download PDF

Info

Publication number
JP2017516510A
JP2017516510A JP2016559409A JP2016559409A JP2017516510A JP 2017516510 A JP2017516510 A JP 2017516510A JP 2016559409 A JP2016559409 A JP 2016559409A JP 2016559409 A JP2016559409 A JP 2016559409A JP 2017516510 A JP2017516510 A JP 2017516510A
Authority
JP
Japan
Prior art keywords
drug
diff
substance
subject
characteristic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016559409A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017516510A5 (enExample
Inventor
キラン ハミルトン ジェイ． デリーモア
キラン ハミルトン ジェイ． デリーモア
モルタザ ブルト
モルタザ ブルト
ロナルダス マリア アーツ
ロナルダス マリア アーツ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koninklijke Philips NV
Original Assignee
Koninklijke Philips NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koninklijke Philips NV filed Critical Koninklijke Philips NV
Publication of JP2017516510A publication Critical patent/JP2017516510A/ja
Publication of JP2017516510A5 publication Critical patent/JP2017516510A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
    • A61B5/0022—Monitoring a patient using a global network, e.g. telephone networks, internet
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4833—Assessment of subject's compliance to treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6887—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient mounted on external non-worn devices, e.g. non-medical devices
    • A61B5/6898—Portable consumer electronic devices, e.g. music players, telephones, tablet computers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient; User input means
    • A61B5/746—Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/0076—Medicament distribution means
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/13—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
    • G16Z99/00—Subject matter not provided for in other main groups of this subclass
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Multimedia (AREA)
  • Physiology (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
JP2016559409A 2014-03-31 2015-03-18 薬物の効果及び相互作用を非侵襲的にモニタ及び識別するための方法並びに装置 Pending JP2017516510A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14162834.7 2014-03-31
EP14162834 2014-03-31
PCT/EP2015/055602 WO2015150069A1 (en) 2014-03-31 2015-03-18 Method and device for the non-invasive monitoring and identification of drug effects and interactions

Publications (2)

Publication Number Publication Date
JP2017516510A true JP2017516510A (ja) 2017-06-22
JP2017516510A5 JP2017516510A5 (enExample) 2018-04-26

Family

ID=50434002

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016559409A Pending JP2017516510A (ja) 2014-03-31 2015-03-18 薬物の効果及び相互作用を非侵襲的にモニタ及び識別するための方法並びに装置

Country Status (5)

Country Link
US (1) US10555699B2 (enExample)
EP (1) EP3125744A1 (enExample)
JP (1) JP2017516510A (enExample)
CN (1) CN106455996B (enExample)
WO (1) WO2015150069A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105678111B (zh) * 2016-02-01 2018-09-14 西安理工大学 基于植物电信号的作物耐盐性评价方法
US10839961B2 (en) * 2017-05-05 2020-11-17 International Business Machines Corporation Identifying drug-to-drug interactions in medical content and applying interactions to treatment recommendations
US11404147B2 (en) 2017-05-05 2022-08-02 International Business Machines Corporation Treatment recommendations based on drug-to-drug interactions
EP3415137A1 (en) * 2017-06-16 2018-12-19 Koninklijke Philips N.V. Harvesting energy during compression of a pill pack
EP3658218A4 (en) * 2017-07-28 2021-03-31 Galvani Bioelectronics Limited TREATMENT OF EYE DISORDERS
WO2019023652A1 (en) * 2017-07-28 2019-01-31 Galvani Bioelectronics Limited TREATMENT OF OCULAR DISORDERS
US10902943B2 (en) 2018-05-17 2021-01-26 International Business Machines Corporation Predicting interactions between drugs and foods
CN110767270A (zh) * 2019-11-01 2020-02-07 南京未来医院研究院有限公司 一种虚拟药物试验系统
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080021345A1 (en) * 2006-06-28 2008-01-24 Kern Steven E Distinguishing different drug effects from the electroencephalogram
JP2008229330A (ja) * 2007-03-20 2008-10-02 Lifescan Inc 糖尿病管理におけるパターン認識システム及び方法
US20100137786A1 (en) * 2008-02-12 2010-06-03 Alferness Clifton A System and method for actively managing type 1 diabetes mellitus on a personalized basis
JP2010519623A (ja) * 2007-02-18 2010-06-03 アボット ダイアベティス ケア インコーポレイテッド 状況ベース医薬投与量決定提供のための方法及びシステム
JP2010225019A (ja) * 2009-03-25 2010-10-07 Toshiba Corp 薬剤情報管理装置、薬剤情報管理方法、及び薬剤情報管理システム
US20110105914A1 (en) * 2007-06-30 2011-05-05 Drager Medical Ag & Co. Kg Process and device for monitoring a patient during anesthesia and for determining the combined effect of a plurality of anesthetics
JP2012519018A (ja) * 2009-02-26 2012-08-23 モール・リサーチ・アプリケーションズ・リミテッド 糖尿病に関連した治療を自動モニタリングする方法およびシステム

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6968375B1 (en) 1997-03-28 2005-11-22 Health Hero Network, Inc. Networked system for interactive communication and remote monitoring of individuals
US6063026A (en) 1995-12-07 2000-05-16 Carbon Based Corporation Medical diagnostic analysis system
US8388530B2 (en) * 2000-05-30 2013-03-05 Vladimir Shusterman Personalized monitoring and healthcare information management using physiological basis functions
US20020095313A1 (en) 2000-09-28 2002-07-18 Haq Mohamed M. Computer system for assisting a physician
CA2451992C (en) 2001-05-15 2013-08-27 Psychogenics Inc. Systems and methods for monitoring behavior informatics
US20040078218A1 (en) 2002-10-16 2004-04-22 Ellen Badinelli System and apparatus for a consumer to determine food/medicine interactions on a real-time basis
AU2002351275B2 (en) 2001-12-06 2007-12-20 Carefusion 303, Inc. C02 monitored drug infusion system
US20040221855A1 (en) * 2002-10-17 2004-11-11 Paul Ashton Methods for monitoring treatment of disease
EP1419730A1 (en) 2002-11-18 2004-05-19 Industrial Technology Research Institute Non-invasive apparatus system for monitoring autonomic nervous system and uses thereof
EP1522257A1 (en) 2003-10-02 2005-04-13 Industrial Technology Research Institute Non-invasive apparatus system for monitoring drug hepatoxicity
EP1733345A4 (en) * 2004-02-17 2010-11-24 Bodybio Inc NETWORK AND METHODS FOR INTEGRATING RESULTS OF INDIVIDUALIZED CLINICAL TESTS AND NUTRITIONAL TREATMENT
US8150509B2 (en) * 2004-10-21 2012-04-03 Cardiac Pacemakers, Inc. Systems and methods for drug therapy enhancement using expected pharmacodynamic models
US20080234322A1 (en) * 2007-03-20 2008-09-25 University Of Utah Methods and apparatus for drug modeling and displaying drug models
EP2023256A1 (en) * 2007-08-02 2009-02-11 Novo Nordisk A/S Drug administration monitoring
US9075910B2 (en) 2010-03-11 2015-07-07 Philometron, Inc. Physiological monitor system for determining medication delivery and outcome
US20130179184A1 (en) * 2012-01-06 2013-07-11 Katherine L. Hurst Individualized Dosing Technique With Multiple Variables
CN102737165B (zh) * 2012-06-07 2016-02-24 北京太元通软件科技有限公司 临床用药决策支持系统
US9035777B2 (en) 2012-08-24 2015-05-19 Elwha Llc Computational systems and methods for monitoring medication events including use of a camera and data comparison

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080021345A1 (en) * 2006-06-28 2008-01-24 Kern Steven E Distinguishing different drug effects from the electroencephalogram
JP2010519623A (ja) * 2007-02-18 2010-06-03 アボット ダイアベティス ケア インコーポレイテッド 状況ベース医薬投与量決定提供のための方法及びシステム
JP2008229330A (ja) * 2007-03-20 2008-10-02 Lifescan Inc 糖尿病管理におけるパターン認識システム及び方法
US20110105914A1 (en) * 2007-06-30 2011-05-05 Drager Medical Ag & Co. Kg Process and device for monitoring a patient during anesthesia and for determining the combined effect of a plurality of anesthetics
US20100137786A1 (en) * 2008-02-12 2010-06-03 Alferness Clifton A System and method for actively managing type 1 diabetes mellitus on a personalized basis
JP2012519018A (ja) * 2009-02-26 2012-08-23 モール・リサーチ・アプリケーションズ・リミテッド 糖尿病に関連した治療を自動モニタリングする方法およびシステム
JP2010225019A (ja) * 2009-03-25 2010-10-07 Toshiba Corp 薬剤情報管理装置、薬剤情報管理方法、及び薬剤情報管理システム

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
MARIER, J.M., ET AL.: "The Effect of AST-120 on the Single-Dose Pharmacokinetics of Losartan and Losartan Acid (E-3174) in", JOURNAL OF CLINICAL PHARMACOLOGY, vol. 46, no. 3, JPN6018048223, March 2006 (2006-03-01), pages 310 - 320, ISSN: 0003935447 *
ZHOU, H., ET AL.: "Nateglinide, a New Mealtime Glucose Regulator. Lack of Pharmacokinetic Interaction with Digoxin in H", CLINICAL DRUG INVESTIGATION, vol. 19, no. 6, JPN6018048222, June 2000 (2000-06-01), pages 465 - 471, ISSN: 0004064910 *
伊賀立二: "これだけは知っておきたい薬物と食物の相互作用 (1) 薬の相互作用とは", 臨床栄養, vol. 89, no. 1, JPN6018048220, July 1996 (1996-07-01), pages 73 - 79, ISSN: 0003935445 *
石澤優, 小松英忠: "HIVプロテアーゼ阻害薬アンプレナビル(プローゼ力プセル)の薬理学的特性と臨床効果", 日本薬理学雑誌, vol. 117, no. 1, JPN6018048221, January 2001 (2001-01-01), pages 59 - 64, ISSN: 0003935446 *

Also Published As

Publication number Publication date
WO2015150069A8 (en) 2016-04-21
EP3125744A1 (en) 2017-02-08
CN106455996B (zh) 2020-09-29
WO2015150069A1 (en) 2015-10-08
CN106455996A (zh) 2017-02-22
US10555699B2 (en) 2020-02-11
US20170027505A1 (en) 2017-02-02

Similar Documents

Publication Publication Date Title
CN106455996B (zh) 用于无创地监测和识别药物效应和相互作用的方法和设备
Chatrati et al. Smart home health monitoring system for predicting type 2 diabetes and hypertension
US12295708B2 (en) Remote patient management and monitoring systems and methods
JP6704076B2 (ja) 医療施設の複数のソースからのデータに基づく患者リスク評価
JP6865162B2 (ja) モニタリング情報提供装置及び方法
CN101573073B (zh) 用于危险分层的患者间比较
US7606617B2 (en) Urinalysis for the early detection of and recovery from worsening heart failure
JP2019072467A (ja) 生体情報センサーの誤差補正装置及び方法、ならびに生体情報推定装置及び方法
JP2022527174A (ja) 術中臨床意思決定支援システム
JP6367825B2 (ja) ユーザーをモニタリングするためのシステム
EP3416542A1 (en) System and method for determining a hemodynamic instability risk score for pediatric subjects
CN115551579B (zh) 用于评估通风患者状况的系统和方法
WO2015161591A1 (zh) 人体生命、健康、运动管理服务系统及方法
CN109770881A (zh) 一种基于血压的健康监测方法及血压测量装置
US20220202350A1 (en) Multiparameter noninvasive sepsis monitor
US12394522B2 (en) System, apparatus, and methods for health monitoring
WO2022198058A1 (en) System, apparatus, and methods for health monitoring
US12089969B2 (en) Personalized alarm settings
US20180353115A1 (en) Portable device case for pulse oximetry measurements
NYIRANEZA Design of a wearable device to track heart problems
CN116528758A (zh) 用于自动确定可量化评分的方法和系统

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180315

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180315

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20181128

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20181211

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20190705